Letter to the Editor
Transaminase Elevation Secondary to the Use of Adalimumab
Elevación de transaminasas secundaria a uso de adalimumab
Read
13574
Timeswas read the article
2474
Total PDF
11100
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 9 | 2 | 11 |
| 2025 5 | 551 | 44 | 595 |
| 2025 4 | 286 | 39 | 325 |
| 2025 3 | 257 | 42 | 299 |
| 2025 2 | 327 | 39 | 366 |
| 2025 1 | 321 | 46 | 367 |
| 2024 12 | 256 | 35 | 291 |
| 2024 11 | 169 | 55 | 224 |
| 2024 10 | 148 | 37 | 185 |
| 2024 9 | 173 | 14 | 187 |
| 2024 8 | 166 | 54 | 220 |
| 2024 7 | 234 | 35 | 269 |
| 2024 6 | 187 | 41 | 228 |
| 2024 5 | 197 | 29 | 226 |
| 2024 4 | 150 | 24 | 174 |
| 2024 3 | 167 | 44 | 211 |
| 2024 2 | 181 | 47 | 228 |
| 2024 1 | 160 | 24 | 184 |
| 2023 12 | 138 | 31 | 169 |
| 2023 11 | 136 | 34 | 170 |
| 2023 10 | 151 | 34 | 185 |
| 2023 9 | 127 | 34 | 161 |
| 2023 8 | 132 | 10 | 142 |
| 2023 7 | 136 | 46 | 182 |
| 2023 6 | 155 | 23 | 178 |
| 2023 5 | 141 | 26 | 167 |
| 2023 4 | 92 | 10 | 102 |
| 2023 3 | 144 | 30 | 174 |
| 2023 2 | 101 | 27 | 128 |
| 2023 1 | 116 | 22 | 138 |
| 2022 12 | 99 | 32 | 131 |
| 2022 11 | 78 | 22 | 100 |
| 2022 10 | 130 | 25 | 155 |
| 2022 9 | 103 | 34 | 137 |
| 2022 8 | 117 | 46 | 163 |
| 2022 7 | 97 | 31 | 128 |
| 2022 6 | 92 | 43 | 135 |
| 2022 5 | 94 | 44 | 138 |
| 2022 4 | 87 | 52 | 139 |
| 2022 3 | 119 | 48 | 167 |
| 2022 2 | 98 | 41 | 139 |
| 2022 1 | 131 | 39 | 170 |
| 2021 12 | 97 | 40 | 137 |
| 2021 11 | 93 | 49 | 142 |
| 2021 10 | 140 | 44 | 184 |
| 2021 9 | 96 | 38 | 134 |
| 2021 8 | 88 | 35 | 123 |
| 2021 7 | 85 | 28 | 113 |
| 2021 6 | 100 | 35 | 135 |
| 2021 5 | 88 | 35 | 123 |
| 2021 4 | 190 | 87 | 277 |
| 2021 3 | 120 | 29 | 149 |
| 2021 2 | 61 | 29 | 90 |
| 2021 1 | 49 | 24 | 73 |
| 2020 12 | 63 | 24 | 87 |
| 2020 11 | 55 | 22 | 77 |
| 2020 10 | 59 | 11 | 70 |
| 2020 9 | 55 | 22 | 77 |
| 2020 8 | 52 | 26 | 78 |
| 2020 7 | 41 | 18 | 59 |
| 2020 6 | 60 | 23 | 83 |
| 2020 5 | 40 | 13 | 53 |
| 2020 4 | 30 | 15 | 45 |
| 2020 3 | 13 | 11 | 24 |
| 2020 2 | 1 | 0 | 1 |
| 2019 1 | 2 | 0 | 2 |
| 2018 5 | 13 | 1 | 14 |
| 2018 4 | 94 | 10 | 104 |
| 2018 3 | 116 | 7 | 123 |
| 2018 2 | 76 | 2 | 78 |
| 2018 1 | 69 | 4 | 73 |
| 2017 12 | 74 | 5 | 79 |
| 2017 11 | 49 | 6 | 55 |
| 2017 10 | 56 | 2 | 58 |
| 2017 9 | 55 | 7 | 62 |
| 2017 8 | 50 | 6 | 56 |
| 2017 7 | 45 | 7 | 52 |
| 2017 6 | 70 | 11 | 81 |
| 2017 5 | 76 | 12 | 88 |
| 2017 4 | 59 | 4 | 63 |
| 2017 3 | 69 | 4 | 73 |
| 2017 2 | 229 | 8 | 237 |
| 2017 1 | 46 | 4 | 50 |
| 2016 12 | 125 | 17 | 142 |
| 2016 11 | 105 | 6 | 111 |
| 2016 10 | 147 | 24 | 171 |
| 2016 9 | 217 | 11 | 228 |
| 2016 8 | 107 | 6 | 113 |
| 2016 7 | 66 | 13 | 79 |
| 2015 12 | 2 | 0 | 2 |
| 2015 9 | 1 | 0 | 1 |
| 2015 8 | 2 | 0 | 2 |
| 2015 7 | 28 | 5 | 33 |
| 2015 6 | 50 | 8 | 58 |
| 2015 5 | 69 | 13 | 82 |
| 2015 4 | 70 | 21 | 91 |
| 2015 3 | 37 | 13 | 50 |
| 2015 2 | 45 | 9 | 54 |
| 2015 1 | 74 | 25 | 99 |
| 2014 12 | 50 | 17 | 67 |
| 2014 11 | 46 | 14 | 60 |
| 2014 10 | 49 | 16 | 65 |
| 2014 9 | 40 | 12 | 52 |
| 2014 8 | 45 | 26 | 71 |
| 2014 7 | 48 | 25 | 73 |
Show all
